Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Crestchem Ltd (CRSTCHM) is currently trading at 137.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Crestchem Limited, founded in April 1991, operates in the specialty chemicals sector, focusing on processing, manufacturing, trading, and marketing innovative chemical ingredients. The company focuses on Caprylic/Capric Triglycerides, which are available in both oil and powder form, used across various industrial applications. Crestchem Limited has developed Capric/Caprylic Triglycerides and Lactose Free products, showcasing its innovation in nutritional chemicals through indigenous technology. The firm leverages its strong innovation capabilities to introduce new chemical solutions, enhancing its market position. Despite lacking recent operational data, the emphasis on product development suggests a strategic focus on expanding its specialty chemicals portfolio.
Over the past 52 weeks, Crestchem Ltd has traded between a low of ₹73.01 and a high of ₹181.55. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Crestchem Ltd has a market capitalization of approximately 41.19. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Crestchem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 16.61 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 41.19 Cr, Crestchem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Crestchem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Crestchem Ltd is 16.61. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Crestchem Limited, founded in April 1991, operates in the specialty chemicals sector, focusing on processing, manufacturing, trading, and marketing innovative chemical ingredients.
The company focuses on Caprylic/Capric Triglycerides, which are available in both oil and powder form, used across various industrial applications.
Crestchem Limited has developed Capric/Caprylic Triglycerides and Lactose Free products, showcasing its innovation in nutritional chemicals through indigenous technology.
The firm leverages its strong innovation capabilities to introduce new chemical solutions, enhancing its market position.
Despite lacking recent operational data, the emphasis on product development suggests a strategic focus on expanding its specialty chemicals portfolio.
Chemicals & Petrochemicals
Specialty Chemicals
41 Cr
High Risk
16.6
44.8
0.2
4.2
181.55
73.01
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
Insider Trading Disclosure
Crestchem Ltd disclosed that Ms. Sonal Dushyant Patel (Member of Promoter Group) sold 9305 equity shares on 23/06/2026 through market transactions for 1296822/- and holds 5295 shares after the sale (intimated 24/06/2026).
Audited Results & Dividend
Board approved standalone and consolidated audited financial results for quarter and year ended Mar 31, 2026; recommended final dividend of Rs.1.50/share (15%), approved Oleo Biosciences subsidiary and up to Rs.2.25 Cr investment, and key reappointments.
Results & Dividend
Board approved standalone & consolidated audited financial results for the quarter/year ended Mar 31, 2026; recommended a final dividend of Rs 1.50/share (15%); noted formation of OLEO BIOSCIENCES Pvt Ltd, approved up to Rs 2.25 Cr investment, and reappointed key personnel.
Results & Dividend
Board approved standalone & consolidated audited results for the quarter and year ended Mar 31, 2026; recommended final dividend of Rs.1.50/share (15%); noted new subsidiary OLEO BIOSCIENCES Pvt Ltd, approved up to Rs.2.25 Cr investment and KMP reappointments.
Audited Results & Dividend
Board approved audited standalone & consolidated Ind AS financial results for Q4/FY2025-26, recommended a final dividend of Rs.1.50 per share, noted formation of OLEO BIOSCIENCES Pvt Ltd, approved up to Rs.2.25 Cr investment and KMP reappointments.
Bearish
3
Neutral
6
Bullish
5
Bearish
19
Neutral
6
Bullish
21
Bearish
16
Neutral
0
Bullish
16
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
49.49 | 53 Cr | 96.07 | 2.79 | 0.00 | 2.95 | 3.34 | 1.46 | ||
137.00 | 41 Cr | 16.61 | 4.16 | 1.09 | 27.45 | 38.11 | — | ||
24.75 | 40 Cr | 495.00 | 2.36 | 0.00 | 0.45 | 5.14 | 0.00 | ||
13.04 | 35 Cr | -12.03 | 0.04 | 0.00 | -0.35 | -0.32 | -0.18 | ||
55.53 | 33 Cr | 87.68 | 0.00 | 0.00 | -32.67 | -33.18 | 3.82 | ||
107.70 | 33 Cr | 17.93 | 0.65 | 0.93 | 3.65 | 5.97 | 2.36 | ||
| Median: 6 Co. | — | 52.51 | 37 Cr | 52.81 | 1.50 | 0.00 | 1.70 | 4.24 | 1.46 |
